|Bid||92.19 x 1000|
|Ask||92.19 x 900|
|Day's Range||90.89 - 92.61|
|52 Week Range||70.89 - 94.56|
|Beta (5Y Monthly)||0.46|
|PE Ratio (TTM)||32.49|
|Forward Dividend & Yield||2.76 (3.05%)|
|Ex-Dividend Date||Mar 14, 2022|
|1y Target Est||N/A|
Kevin Outterson has spent the better part of the last year in conversations with CARB-X's previous backers. Now, those efforts have yielded fruit: The organization has another $370 million to invest in research targeting drug-resistant bacteria.
Drug/biotech companies are likely to see significant advances in innovation in 2022. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and Glaxo (GSK) are worth retaining in your portfolio.
In this article, we will discuss the 12 best DOW stocks to buy according to hedge funds. If you want to explore similar stock options, you can also take a look at 5 Best DOW Stocks To Buy According To Hedge Funds. The Dow Jones Industrial Average is a price-weighted index that consists of 30 […]